Plunkett Research Online: Quince Therapeutics Inc

QUINCE THERAPEUTICS INC (QNCX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Quince Therapeutics, Inc., formerly Cortexyme, Inc., is a late-stage biopharmaceutical company dedicated to advancing innovative precision therapeutics for debilitating and rare diseases. The firm’s Autologous Intracellular Drug Encapsulation (AIDE) technology platform is a drug/device combination .....



Quince Therapeutics Inc
Ticker: QNCX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 415 910-5717
Fax:
Address: 611 Gateway Boulevard
Suite 273
South San Francisco, CA 94080 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description
Dirk ThyeCEO/Director/Other Executive Officer
Brendan HannahCFO/Chief Accounting Officer/Chief Compliance Officer/COO/Other Executive Officer
See More
Quince Therapeutics, Inc., formerly Cortexyme, Inc., is a late-stage biopharmaceutical company dedicated to advancing innovative precision therapeutics for debilitating and rare diseases. The firm’s Autologous Intracellular Drug Encapsulation (AIDE) technology platform is a drug/device combination .....See More See More

Auditor: BDO USA, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
AIDE
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: